---
title: "Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286428001.md"
description: "Oppenheimer analyst reiterated a Buy rating on Acrivon Therapeutics, Inc. today and set a price target of $8.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Acrivon Therapeutics, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $12.25."
datetime: "2026-05-14T13:39:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286428001.md)
  - [en](https://longbridge.com/en/news/286428001.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286428001.md)
---

# Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer

Oppenheimer analyst reiterated a Buy rating on Acrivon Therapeutics, Inc. today and set a price target of $8.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Acrivon Therapeutics, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $12.25.

### Related Stocks

- [ACRV.US](https://longbridge.com/en/quote/ACRV.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)

## Related News & Research

- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News](https://longbridge.com/en/news/286772955.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)